Copyright Reports & Markets. All rights reserved.

Global Continuous Glucose Monitoring Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Continuous Glucose Monitoring Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Continuous Glucose Monitoring Market Size Growth Rate by Product
      • 1.4.2 Transmitter and receivers
      • 1.4.3 Sensors
      • 1.4.4 Insulin pump
    • 1.5 Market by End User
      • 1.5.1 Global Continuous Glucose Monitoring Market Size Growth Rate by End User
      • 1.5.2 Diagnostics/clinics
      • 1.5.3 Hospitals
      • 1.5.4 Home settings
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Continuous Glucose Monitoring Market Size
      • 2.1.1 Global Continuous Glucose Monitoring Revenue 2014-2025
      • 2.1.2 Global Continuous Glucose Monitoring Sales 2014-2025
    • 2.2 Continuous Glucose Monitoring Growth Rate by Regions
      • 2.2.1 Global Continuous Glucose Monitoring Sales by Regions
      • 2.2.2 Global Continuous Glucose Monitoring Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Continuous Glucose Monitoring Sales by Manufacturers
      • 3.1.1 Continuous Glucose Monitoring Sales by Manufacturers
      • 3.1.2 Continuous Glucose Monitoring Sales Market Share by Manufacturers
      • 3.1.3 Global Continuous Glucose Monitoring Market Concentration Ratio (CR5 and HHI)
    • 3.2 Continuous Glucose Monitoring Revenue by Manufacturers
      • 3.2.1 Continuous Glucose Monitoring Revenue by Manufacturers (2014-2019)
      • 3.2.2 Continuous Glucose Monitoring Revenue Share by Manufacturers (2014-2019)
    • 3.3 Continuous Glucose Monitoring Price by Manufacturers
    • 3.4 Continuous Glucose Monitoring Manufacturing Base Distribution, Product Types
      • 3.4.1 Continuous Glucose Monitoring Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Continuous Glucose Monitoring Product Type
      • 3.4.3 Date of International Manufacturers Enter into Continuous Glucose Monitoring Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Continuous Glucose Monitoring Sales by Product
    • 4.2 Global Continuous Glucose Monitoring Revenue by Product
    • 4.3 Continuous Glucose Monitoring Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Continuous Glucose Monitoring Breakdown Data by End User

    6 North America

    • 6.1 North America Continuous Glucose Monitoring by Countries
      • 6.1.1 North America Continuous Glucose Monitoring Sales by Countries
      • 6.1.2 North America Continuous Glucose Monitoring Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Continuous Glucose Monitoring by Product
    • 6.3 North America Continuous Glucose Monitoring by End User

    7 Europe

    • 7.1 Europe Continuous Glucose Monitoring by Countries
      • 7.1.1 Europe Continuous Glucose Monitoring Sales by Countries
      • 7.1.2 Europe Continuous Glucose Monitoring Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Continuous Glucose Monitoring by Product
    • 7.3 Europe Continuous Glucose Monitoring by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Continuous Glucose Monitoring by Countries
      • 8.1.1 Asia Pacific Continuous Glucose Monitoring Sales by Countries
      • 8.1.2 Asia Pacific Continuous Glucose Monitoring Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Continuous Glucose Monitoring by Product
    • 8.3 Asia Pacific Continuous Glucose Monitoring by End User

    9 Central & South America

    • 9.1 Central & South America Continuous Glucose Monitoring by Countries
      • 9.1.1 Central & South America Continuous Glucose Monitoring Sales by Countries
      • 9.1.2 Central & South America Continuous Glucose Monitoring Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Continuous Glucose Monitoring by Product
    • 9.3 Central & South America Continuous Glucose Monitoring by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Continuous Glucose Monitoring by Countries
      • 10.1.1 Middle East and Africa Continuous Glucose Monitoring Sales by Countries
      • 10.1.2 Middle East and Africa Continuous Glucose Monitoring Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Continuous Glucose Monitoring by Product
    • 10.3 Middle East and Africa Continuous Glucose Monitoring by End User

    11 Company Profiles

    • 11.1 Medtronic plc
      • 11.1.1 Medtronic plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Medtronic plc Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Medtronic plc Continuous Glucose Monitoring Products Offered
      • 11.1.5 Medtronic plc Recent Development
    • 11.2 Abbott
      • 11.2.1 Abbott Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Abbott Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Abbott Continuous Glucose Monitoring Products Offered
      • 11.2.5 Abbott Recent Development
    • 11.3 DexCom
      • 11.3.1 DexCom Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 DexCom Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 DexCom Continuous Glucose Monitoring Products Offered
      • 11.3.5 DexCom Recent Development
    • 11.4 Echo
      • 11.4.1 Echo Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Echo Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Echo Continuous Glucose Monitoring Products Offered
      • 11.4.5 Echo Recent Development
    • 11.5 Insulet
      • 11.5.1 Insulet Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Insulet Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Insulet Continuous Glucose Monitoring Products Offered
      • 11.5.5 Insulet Recent Development
    • 11.6 Johnson & Johnson
      • 11.6.1 Johnson & Johnson Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Johnson & Johnson Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Johnson & Johnson Continuous Glucose Monitoring Products Offered
      • 11.6.5 Johnson & Johnson Recent Development
    • 11.7 Senseonics
      • 11.7.1 Senseonics Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Senseonics Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Senseonics Continuous Glucose Monitoring Products Offered
      • 11.7.5 Senseonics Recent Development
    • 11.8 Roche
      • 11.8.1 Roche Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Roche Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Roche Continuous Glucose Monitoring Products Offered
      • 11.8.5 Roche Recent Development
    • 11.9 AgaMatrix
      • 11.9.1 AgaMatrix Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 AgaMatrix Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 AgaMatrix Continuous Glucose Monitoring Products Offered
      • 11.9.5 AgaMatrix Recent Development
    • 11.10 GlySure
      • 11.10.1 GlySure Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 GlySure Continuous Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 GlySure Continuous Glucose Monitoring Products Offered
      • 11.10.5 GlySure Recent Development
    • 11.11 OrSense
    • 11.12 Ypsomed
    • 11.13 Animas

    12 Future Forecast

    • 12.1 Continuous Glucose Monitoring Market Forecast by Regions
      • 12.1.1 Global Continuous Glucose Monitoring Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Continuous Glucose Monitoring Revenue Forecast by Regions 2019-2025
    • 12.2 Continuous Glucose Monitoring Market Forecast by Product
      • 12.2.1 Global Continuous Glucose Monitoring Sales Forecast by Product 2019-2025
      • 12.2.2 Global Continuous Glucose Monitoring Revenue Forecast by Product 2019-2025
    • 12.3 Continuous Glucose Monitoring Market Forecast by End User
    • 12.4 North America Continuous Glucose Monitoring Forecast
    • 12.5 Europe Continuous Glucose Monitoring Forecast
    • 12.6 Asia Pacific Continuous Glucose Monitoring Forecast
    • 12.7 Central & South America Continuous Glucose Monitoring Forecast
    • 12.8 Middle East and Africa Continuous Glucose Monitoring Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Continuous Glucose Monitoring Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      A CGM provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management.
      Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices, which has increased the adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps that are bridged by the innovative CGM. With CGM, significant improvement has been observed in stabilizing the elevated A1C levels, which in turn reduced the risk of developing long-term diabetic complications.
      The global Continuous Glucose Monitoring market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Continuous Glucose Monitoring market based on company, product type, end user and key regions.

      This report studies the global market size of Continuous Glucose Monitoring in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Continuous Glucose Monitoring in these regions.
      This research report categorizes the global Continuous Glucose Monitoring market by top players/brands, region, type and end user. This report also studies the global Continuous Glucose Monitoring market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Medtronic plc
      Abbott
      DexCom
      Echo
      Insulet
      Johnson & Johnson
      Senseonics
      Roche
      AgaMatrix
      GlySure
      OrSense
      Ypsomed
      Animas

      Market size by Product
      By devices
      Transmitter and receivers
      Sensors
      Insulin pump
      By age
      Children and teens
      Youth
      Middle, elderly and aged
      Market size by End User
      Diagnostics/clinics
      Hospitals
      Home settings

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Continuous Glucose Monitoring market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Continuous Glucose Monitoring market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Continuous Glucose Monitoring companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Continuous Glucose Monitoring submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Continuous Glucose Monitoring are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Continuous Glucose Monitoring market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now